(Q33300855)

25 July 2017

title

Apparent beneficial effects of tamoxifen on bone mineral content in patients with breast cancer: preliminary study (English)

1 reference

25 July 2017

Apparent beneficial effects of tamoxifen on bone mineral content in patients with breast cancer: Preliminary study (English)

1 reference

27 November 2022

1 reference

W. G. Ryan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1790419

27 November 2022

J. Wolter

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1790419

27 November 2022

J. D. Bagdade

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1790419

27 November 2022

language of work or name

English

0 references

publication date

1 October 1991

1 reference

full work available at URL

25 July 2017

http://link.springer.com/content/pdf/10.1007/BF01627077.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF01627077/fulltext.html

27 November 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF01627077

27 November 2022

1 reference

Osteoporosis International

27 November 2022

published in

1 reference

25 July 2017

volume

2

1 reference

25 July 2017

issue

1

1 reference

25 July 2017

page(s)

39-41

1 reference

Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer

25 July 2017

cites work

1 reference

12 December 2020

Effects of the antiestrogens tamoxifen and clomiphene on bone resorption in vitro

1 reference

12 December 2020

Amelioration of postmenopausal primary hyperparathyroidism during adjuvant tamoxifen for breast cancer

1 reference

12 December 2020

Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two years

1 reference

12 December 2020

Tamoxifen in the treatment of breast cancer

1 reference

12 December 2020

Bone mineral content of women receiving tamoxifen for mastalgia

1 reference

12 December 2020

Tamoxifen prevents the skeletal effects of ovarian hormone deficiency in rats

1 reference

12 December 2020

The effect of tamoxifen on bone mineral content in premenopausal women with breast cancer

1 reference

12 December 2020

Effects of tamoxifen on spinal bone density in women with breast cancer

1 reference

12 December 2020

Antiestrogen and antiandrogen administration reduce bone mass in the rat.

1 reference

12 December 2020

Evidence of estrogen receptors in normal human osteoblast-like cells

1 reference

12 December 2020

Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Analysis at six years by Nolvadex Adjuvant Trial Organisation

1 reference

12 December 2020

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.

1 reference

12 December 2020

Effects of tamoxifen treatment on plasma lipids and lipoprotein lipid composition

1 reference

12 December 2020

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

1 reference

12 December 2020

The effects of tamoxifen on the osteopenia induced by sciatic neurotomy in the rat: a histomorphometric study

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01627077

1 reference

25 July 2017

1 reference